AM
Andrea M.Verified purchase
Your cart is empty
Add prompt packs to continue
Copy, paste and use them in your favorite AI:
Just $0.08 per prompt · one-time payment
100 resources included
This exclusive collection of prompts represents the cutting edge of instructional engineering applied to modern Urology. Designed by experts in instructional design, each tool allows the specialist to optimize clinical processes, from the analysis of complex oncological pathologies to the technical precision in state-of-the-art endourological procedures. By integrating these prompts into their daily practice, professionals will be able to generate personalized follow-up protocols, synthesize recent medical literature, and improve diagnostic communication with the patient. It is the definitive solution to transform the operational efficiency of the urological consultation, guaranteeing international quality standards and academic precision in each healthcare interaction.
He acts as an expert physician in Urological Oncology and precision medicine, specialized in the early diagnosis of prostate adenocarcinoma. Your objective is to perform a critical evaluation and multivariable risk stratification for a male patient of [Patient Age] years old who comes for evaluation of his Prostate Specific Antigen (PSA) levels. Analyze the following clinical data provided: - Current Total PSA: [Value in ng/mL] - PSA Kinetics (Speed or Doubling Time): [Historical data] - Free/Total PSA Ratio: [Percentage if available] - PSA Density (PSAD): [Calculated on prostate volume of [Volume in cc]] - Rectal Examination Findings (DRE): [Describe: Normal, Nodule, Stoney, Induration] - Additional risk factors: [First-degree family history, race, genetic mutations known as BRCA2]. Using the current clinical guidelines of the EAU (European Association of Urology) and the AUA (American Urological Association) as a framework of reference, it determines whether the current values justify a direct referral to a biopsy or whether it is mandatory to request a prior Multiparametric Magnetic Resonance (MPMR). It evaluates the probability of clinically significant prostate cancer (Gleason >= 7) against the possibility of overdiagnosis of indolent tumors or benign elevations due to Benign Prostate Hyperplasia (BPH) or prostatitis. Provides a diagnostic synthesis that includes: 1. Interpretation of biomarkers in the context of age and glandular volume. 2. Risk calculation based on predictive models (such as the ERSPC or PBCP calculator). 3. Technical recommendation on the type of biopsy (Fusion, Systematic or Transperineal) in case of suspicion. 4. Personalized monitoring plan if levels do not reach the threshold for immediate intervention. If any key information needed to fill the bracketed fields is missing, ask me the necessary questions before answering.
Instant access after purchase from your dashboard. Just copy and paste into your AI.
ChatGPT, Claude, Gemini, DeepSeek, Grok, Qwen and any AI chat.
Yes. Every prompt includes bracketed fields where you insert your own information, context and specifics, so they fit your situation, country or industry.
Yes. Above you can read full sample prompts, exactly as you'll receive them, to check the quality before paying.
Yes. Pay once and they're yours forever, updates included.
Acts as an expert urological oncologist and senior clinical consultant. Your objective is to design a comprehensive and personalized adjuvant intravesical chemotherapy protocol for a patient with a recent diagnosis of Non-Muscle-Invasive Bladder Cancer (NMIBC). The patient is [EDAD] years old and has the following relevant history: [COMORBILIDADES Y ANTECEDENTES]. He recently underwent Transurethral Bladder Resection (TUR-V) with the following findings: [ESTADIO T, GRADO, MULTIFOCALIDAD, PRESENCIA DE CIS]. First, perform a detailed risk stratification following the latest guidelines from the EAU (European Association of Urology) or the AUA (American Urological Association). Classify the patient into a risk category (Low, Intermediate, or High) and justify this classification based on the data provided on tumor size, recurrence, and histology. Evaluates whether the patient is an ideal candidate for [AGENTE: MITOMICINA C / GEMCITABINA] administration or whether BCG immunotherapy should be considered instead. Develop a complete therapeutic scheme that includes: 1. Induction phase (specifying exact dose, dilution volume, weekly frequency and total duration). 2. Maintenance strategy (if applicable, detailing the periodicity over the next few months or years). 3. Technical administration protocol (instructions on drug retention time, patient position rotation, prior water restrictions and optimization of urinary pH if Mitomycin C is used). Provides comprehensive guidance for managing adverse effects and complications. Identify the symptoms of chemical cystitis, dermatological toxicity and systemic reactions, offering pharmacological solutions or specific dosage adjustments for each case. It includes clear criteria for temporary or permanent suspension of treatment based on the patient's tolerance and the integrity of the bladder mucosa observed in the reviews. The document ends with a post-intravesical chemotherapy follow-up plan. It details the schedule of control cystoscopy and urinary cytology for the next 24 months, and establishes the indicators of success or failure of adjuvant treatment. It also provides a section of practical advice for the patient on safety at home after instillation (management of excreta and precautions in sexual activity). If any key information needed to fill the bracketed fields is missing, ask me the necessary questions before answering.
He acts as a medical oncologist subspecialized in oncological urology with extensive experience in the management of tumors of the upper and lower urinary tract. Your objective is to perform a comprehensive clinical review and propose a therapeutic management plan for a patient diagnosed with advanced or metastatic urothelial carcinoma, strictly based on the updated EAU (European Association of Urology) and ESMO guidelines. Patient-specific data are: [PATIENT AGE], [ECOG PERFORMANCE STATUS], [CREATININE CLEARANCE (CrCl)], [METASTASIS SITE], and [PD-L1 EXPRESSION STATUS]. Analyzes in depth the selection of the first line of treatment. If patient is platinum eligible, compare the benefit of induction chemotherapy followed by maintenance with Avelumab (based on the JAVELIN Bladder 100 study) versus the new standard combination of Enfortumab Vedotin and Pembrolizumab (study EV-302/KEYNOTE-A39). You must justify the choice based on the reported comorbidities and the toxicity profile of each regimen, specifically mentioning peripheral neuropathy and the risk of severe skin reactions. Develops a surveillance and management protocol for immune-related adverse events (irAEs). Details the monitoring necessary for the early detection of pneumonitis, colitis, hypophysitis, and immune-mediated nephritis. For each one, it establishes the criteria for temporary or permanent suspension of the immunotherapy drug and the corticosteroid treatment algorithm according to the CTCAE v5.0 severity scale. It also includes considerations on the evaluation of the response using iRECIST criteria, differentiating between true progression and the phenomenon of pseudoprogression. Finally, generate a technical report for the tumor committee that includes: 1) Summary of the scientific evidence that supports the recommendation, 2) Planned therapeutic sequencing in case of progression (second and third line with agents such as Sacituzumab Govitecan or Erdafitinib if there are FGFR mutations), and 3) Recommendations for radiological follow-up and blood/urine biomarkers during treatment with [SELECTED DRUG NAME]. If any key information needed to fill the bracketed fields is missing, ask me the necessary questions before answering.
It's a master instruction, optimized for AI.
Prompt
your instruction
AI
Result
Based on 8 reviews
Exceeded my expectations. They work just as well in ChatGPT and Claude. Totally recommend them.
Exceeded my expectations. They're easy to adapt to my case by just changing the fields. I'll buy again without hesitation.
I was impressed by the quality. The prompts are really well thought out and the effort shows. Totally recommend them.
I was impressed by the quality. They work just as well in ChatGPT and Claude. I'll buy again without hesitation.
Good value for money. Most of them worked on the first try. I'd buy again.
Exactly what I was looking for. The quality of the answers I get improved a lot. Totally recommend them.
Exceeded my expectations. The prompts are really well thought out and the effort shows. One hundred percent recommended.
Worth every penny. The quality of the answers I get improved a lot. Totally recommend them.